ATLASATLAS fair value
₩16,547
Above fair value · 150% premium
Range: ₩12,112–₩22,604Fair valuePrice
Hanmi Science (008930.KO)
Hanmi Science stock price today, ATLAS forecast and fair value
Healthcare · Medical Distribution · Korea Exchange (KOSPI) · South Korea
₩41,400▼ -2.01%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Hanmi Science in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Hanmi Science
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Hanmi Science's fair value at about ₩16,547 per share (reasonable range: ₩12,112 to ₩22,604). At ₩41,400, the stock trades 150% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Hanmi Science a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩35,048 and ₩46,697; in 9 out of 10, between ₩27,175 and ₩60,225. Estimated annual volatility is 89%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩3.0T
- Market cap (USD)
- $2.3B
- P/E ratio
- 19.8
- Dividend yield
- 0.68%
- 52-week high
- ₩63,800
- 52-week low
- ₩25,600
- Revenue (12 months)
- ₩1.4T
- Gross margin
- 23.7%
- Operating margin
- 5.8%
- Net margin
- 10.7%
- Beta
- 0.43
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Hanmi Science sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 008930.KO has traded between ₩25,600 and ₩63,800. Today it is 35.1% below that high and 62% above its low.
On the business: net margin is 10.7%; it trades at 19.8 times earnings.
Its beta is 0.43: it tends to move less than the market.
About the company
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics.
Want to see everything about Hanmi Science?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Hanmi Science (008930.KO) fair value?
About ₩16,547 per share according to ATLAS (reasonable range: ₩12,112 to ₩22,604). With the stock at ₩41,400, it is 150% above it.
What is the chance 008930.KO goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, 008930.KO ends the month between ₩35,048 and ₩46,697.
How big is Hanmi Science and what is its P/E ratio?
Hanmi Science's market capitalization is ₩3.0T. Its price-to-earnings (P/E) ratio is 19.8: you pay ₩19.8 for each ₩1.00 of yearly earnings.
Does Hanmi Science pay a dividend?
Yes. 008930.KO's current dividend yield is 0.68% at today's price (₩41,400).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer